WELDON TURNER: Open Payments
NPI 1891224648 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 35 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $227 |
| Lilly USA, LLC | 10 | $137 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| Lundbeck LLC | 2 | $43 |
| Amgen Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: Ozempic, MOUNJARO, TRELEGY ELLIPTA, REXULTI, SHINGRIX, EVENITY, FREESTYLE LIBRE 3, Wegovy.
Industry payments across TX — which companies pay providers there.
